Drug Eluting Stent News and Research

RSS
A drug-eluting stent (DES) is a coronary stent (a scaffold) placed into narrowed, diseased coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombus), could otherwise block the stented artery, a process called restenosis.

Further Reading

Pharmacyclics reports total GAAP revenues of $2.1 million for third-quarter fiscal 2010

Pharmacyclics reports total GAAP revenues of $2.1 million for third-quarter fiscal 2010

6 May 2010
LightLab Imaging granted FDA clearance for C7-XR Imaging System and C7 Dragonfly Imaging Catheter

LightLab Imaging granted FDA clearance for C7-XR Imaging System and C7 Dragonfly Imaging Catheter

5 May 2010
FDA approves Novartis Pharmaceuticals' Zortress for preventing rejection of kidney transplants

FDA approves Novartis Pharmaceuticals' Zortress for preventing rejection of kidney transplants

22 Apr 2010
Delcath Systems' trial meets primary endpoint of extended hPFS in patients with melanoma metastases

Delcath Systems' trial meets primary endpoint of extended hPFS in patients with melanoma metastases

22 Apr 2010
Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

Abbott's first-quarter worldwide pharmaceutical sales increases by 12.9%

21 Apr 2010
Johnson & Johnson' first-quarter 2010 sales increase 4.0% to $15.6 billion

Johnson & Johnson' first-quarter 2010 sales increase 4.0% to $15.6 billion

21 Apr 2010
Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI

Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI

19 Mar 2010
CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

18 Mar 2010
Hybrid revascularization procedure is safe and feasible for left main coronary artery stenosis

Hybrid revascularization procedure is safe and feasible for left main coronary artery stenosis

16 Mar 2010
PERSEUS clinical program demonstrates positive results of TAXUS Element Paclitaxel-Eluting Stent System

PERSEUS clinical program demonstrates positive results of TAXUS Element Paclitaxel-Eluting Stent System

16 Mar 2010
Medtronic' Endeavor DES demonstrates safety and efficacy profile for coronary artery disease treatment

Medtronic' Endeavor DES demonstrates safety and efficacy profile for coronary artery disease treatment

16 Mar 2010
Drug-eluting stents offer new hope to patients with critical limb ischemia

Drug-eluting stents offer new hope to patients with critical limb ischemia

16 Mar 2010
New trial comparing drug-eluting stents to bypass graft surgery in left main coronary artery disease patients

New trial comparing drug-eluting stents to bypass graft surgery in left main coronary artery disease patients

15 Mar 2010
Tryton Medical announces implantation of Tryton stent for the first time in Portugal and Austria

Tryton Medical announces implantation of Tryton stent for the first time in Portugal and Austria

19 Feb 2010
Boston Scientific reports fourth quarter and full year 2009 results

Boston Scientific reports fourth quarter and full year 2009 results

10 Feb 2010
Abbott declares quarterly dividend of 40 cents per share

Abbott declares quarterly dividend of 40 cents per share

27 Jan 2010
Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

20 Jan 2010
Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

9 Jan 2010
Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

9 Jan 2010
Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

8 Jan 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback